Total Valuation
CYduct Diagnostics has a market cap or net worth of $13.88M. The enterprise value is $2.81M.
Market Cap$13.88M
Enterprise Value$2.81M
Share Statistics
CYduct Diagnostics has 5,141,239 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,141,239
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
CYduct Diagnostics’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 17.33%.
Return on Equity (ROE)0.15
Return on Assets (ROA)-10.98
Return on Invested Capital (ROIC)17.33%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee23.56K
Profits Per Employee-137.87K
Employee Count3
Asset Turnover1.88
Inventory Turnover1.34
Valuation Ratios
The current PE Ratio of CYduct Diagnostics is ―. CYduct Diagnostics’s PEG ratio is 1.83.
PE Ratio―
PS Ratio18.69
PB Ratio-0.47
Price to Fair Value-0.47
Price to FCF-18.36
Price to Operating Cash Flow1.06K
PEG Ratio1.83
Income Statement
In the last 12 months, CYduct Diagnostics had revenue of 70.69K and earned -413.61K in profits. Earnings per share was -0.08.
Revenue70.69K
Gross Profit46.79K
Operating Income-363.22K
Pretax Income-413.61K
Net Income-413.61K
EBITDA-363.22K
Earnings Per Share (EPS)-0.08
Cash Flow
In the last 12 months, operating cash flow was 10.29K and capital expenditures -4.00, giving a free cash flow of 10.29K billion.
Operating Cash Flow10.29K
Free Cash Flow10.29K
Free Cash Flow per Share<0.01
Dividends & Yields
CYduct Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.50
52-Week Price Change725.40%
50-Day Moving Average1.11
200-Day Moving Average0.74
Relative Strength Index (RSI)83.99
Average Volume (3m)116.00
Important Dates
CYduct Diagnostics upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
CYduct Diagnostics as a current ratio of 0.02, with Debt / Equity ratio of -23.16%
Current Ratio0.02
Quick Ratio<0.01
Debt to Market Cap0.54
Net Debt to EBITDA-1.96
Interest Coverage Ratio-7.21
Taxes
In the past 12 months, CYduct Diagnostics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
CYduct Diagnostics EV to EBITDA ratio is -5.60, with an EV/FCF ratio of -28.25.
EV to Sales28.77
EV to EBITDA-5.60
EV to Free Cash Flow-28.25
EV to Operating Cash Flow-28.25
Balance Sheet
CYduct Diagnostics has $8.98K in cash and marketable securities with $709.29K in debt, giving a net cash position of -$700.31K billion.
Cash & Marketable Securities$8.98K
Total Debt$709.29K
Net Cash-$700.31K
Net Cash Per Share-$0.14
Tangible Book Value Per Share-$0.54
Margins
Gross margin is 60.66%, with operating margin of -513.84%, and net profit margin of -585.13%.
Gross Margin60.66%
Operating Margin-513.84%
Pretax Margin-585.13%
Net Profit Margin-585.13%
EBITDA Margin-513.84%
EBIT Margin-513.84%
Analyst Forecast
The average price target for CYduct Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-9.50%
EPS Growth Forecast13.49%